AXQ Capital’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $119K | Buy |
+13,317
| New | +$119K | 0.04% | 505 |
|
2023
Q4 | – | Sell |
-23,134
| Closed | -$164K | – | 645 |
|
2023
Q3 | $164K | Buy |
23,134
+5,600
| +32% | +$39.6K | 0.06% | 403 |
|
2023
Q2 | $123K | Sell |
17,534
-1,300
| -7% | -$9.15K | 0.15% | 229 |
|
2023
Q1 | $157K | Buy |
+18,834
| New | +$157K | 0.06% | 425 |
|